Drug Approval | April 14, 2025
Aurolife Pharma gets 11 observations from USFDA for Raleigh plant
The company does not expect this development to have any material impact on the current business operations
The company does not expect this development to have any material impact on the current business operations
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Alkem Medtech to acquire 100% stake of Bombay Ortho
The European regulator will conduct a re-inspection of the facility to verify the compliance
USFDA inspection at Alembic Pharma's Bioequivalence facility
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
USFDA inspection at Emcure Pharmaceuticals API facility
Subscribe To Our Newsletter & Stay Updated
